Literature DB >> 28560485

Evaluation of end-tidal CO2 pressure at the anaerobic threshold for detecting and assessing pulmonary hypertension.

Akifumi Higashi1, Yoshihiro Dohi2, Sayuri Yamabe1, Hiroki Kinoshita3, Yoshiharu Sada4, Toshiro Kitagawa1, Takayuki Hidaka1, Satoshi Kurisu1, Hideya Yamamoto1, Yuji Yasunobu5, Yasuki Kihara1.   

Abstract

Cardiopulmonary exercise testing (CPET) is useful for the evaluation of patients with suspected or confirmed pulmonary hypertension (PH). End-tidal carbon dioxide pressure (PETCO2) during exercise is reduced with elevated pulmonary artery pressure. However, the utility of ventilatory parameters such as CPET for detecting PH remains unclear. We conducted a review in 155 patients who underwent right heart catheterization and CPET. Fifty-nine patients had PH [mean pulmonary arterial pressure (mPAP) ≥25 mmHg]. There was an inverse correlation between PETCO2 at the anaerobic threshold (AT) and mPAP (r = -0.66; P < 0.01). Multiple regression analysis showed that PETCO2 at the AT was independently associated with an elevated mPAP (P = 0.04). The sensitivity and specificity of CPET for PH were 80 and 86%, respectively, when the cut-off value identified by receiver operating characteristic curve analysis for PETCO2 at the AT was ≤34.7 mmHg. A combination of echocardiography and CPET improved the sensitivity in detecting PH without markedly reducing specificity (sensitivity 87%, specificity 85%). Evaluation of PETCO2 at the AT is useful for estimating pulmonary pressure. A combination of CPET and previous screening algorithms for PH may enhance the diagnostic ability of PH.

Entities:  

Keywords:  Cardiopulmonary exercise testing; End-tidal carbon dioxide pressure; Pulmonary hypertension

Mesh:

Substances:

Year:  2017        PMID: 28560485     DOI: 10.1007/s00380-017-0999-y

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  32 in total

1.  ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines).

Authors:  Raymond J Gibbons; Gary J Balady; J Timothy Bricker; Bernard R Chaitman; Gerald F Fletcher; Victor F Froelicher; Daniel B Mark; Ben D McCallister; Aryan N Mooss; Michael G O'Reilly; William L Winters; Raymond J Gibbons; Elliott M Antman; Joseph S Alpert; David P Faxon; Valentin Fuster; Gabriel Gregoratos; Loren F Hiratzka; Alice K Jacobs; Richard O Russell; Sidney C Smith
Journal:  Circulation       Date:  2002-10-01       Impact factor: 29.690

Review 2.  The impact of pharmacotherapy on the cardiopulmonary exercise test response in patients with heart failure: a mini review.

Authors:  Marco Guazzi; Ross Arena
Journal:  Curr Vasc Pharmacol       Date:  2009-10       Impact factor: 2.719

3.  Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension.

Authors:  Micah R Fisher; Paul R Forfia; Elzbieta Chamera; Traci Housten-Harris; Hunter C Champion; Reda E Girgis; Mary C Corretti; Paul M Hassoun
Journal:  Am J Respir Crit Care Med       Date:  2009-01-22       Impact factor: 21.405

Review 4.  Cardiopulmonary exercise testing in the assessment of pulmonary hypertension.

Authors:  Ross Arena; Marco Guazzi; Jonathan Myers; Daniel Grinnen; Daniel E Forman; Carl J Lavie
Journal:  Expert Rev Respir Med       Date:  2011-04       Impact factor: 3.772

5.  Overestimation by echocardiography of the peak systolic pressure gradient between the right ventricle and right atrium due to tricuspid regurgitation and the usefulness of the early diastolic transpulmonary valve pressure gradient for estimating pulmonary artery pressure.

Authors:  Takuma Hioka; Sanae Kaga; Taisei Mikami; Kazunori Okada; Michito Murayama; Nobuo Masauzi; Masahiro Nakabachi; Hisao Nishino; Shinobu Yokoyama; Mutsumi Nishida; Hiroyuki Iwano; Mamoru Sakakibara; Satoshi Yamada; Hiroyuki Tsutsui
Journal:  Heart Vessels       Date:  2016-12-20       Impact factor: 2.037

6.  Diagnosis of CTEPH versus IPAH using capillary to end-tidal carbon dioxide gradients.

Authors:  S J Scheidl; C Englisch; G Kovacs; F Reichenberger; R Schulz; A Breithecker; H-A Ghofrani; W Seeger; H Olschewski
Journal:  Eur Respir J       Date:  2011-07-07       Impact factor: 16.671

7.  The usefulness of submaximal exercise gas exchange to define pulmonary arterial hypertension.

Authors:  Paul R Woods; Robert P Frantz; Bryan J Taylor; Thomas P Olson; Bruce D Johnson
Journal:  J Heart Lung Transplant       Date:  2011-05-31       Impact factor: 10.247

8.  Abnormal end-tidal PO(2) and PCO(2) at the anaerobic threshold correlate well with impaired exercise gas exchange in patients with left ventricular dysfunction.

Authors:  Hiroto Kano; Akira Koike; Masayo Hoshimoto-Iwamoto; Osamu Nagayama; Koji Sakurada; Takeya Suzuki; Hidekazu Tsuneoka; Hitoshi Sawada; Tadanori Aizawa; Karlman Wasserman
Journal:  Circ J       Date:  2011-11-16       Impact factor: 2.993

9.  Cardiopulmonary exercise testing to evaluate the exercise capacity of patients with inoperable chronic thromboembolic pulmonary hypertension: an endothelin receptor antagonist improves the peak PETCO2.

Authors:  Akihiro Hirashiki; Shiro Adachi; Yoshihisa Nakano; Yuji Kono; Shuzo Shimazu; Shinya Shimizu; Ryota Morimoto; Takahiro Okumura; Kyosuke Takeshita; Sumio Yamada; Toyoaki Murohara; Takahisa Kondo
Journal:  Life Sci       Date:  2014-03-15       Impact factor: 5.037

10.  Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study.

Authors:  J Gerry Coghlan; Christopher P Denton; Ekkehard Grünig; Diana Bonderman; Oliver Distler; Dinesh Khanna; Ulf Müller-Ladner; Janet E Pope; Madelon C Vonk; Martin Doelberg; Harbajan Chadha-Boreham; Harald Heinzl; Daniel M Rosenberg; Vallerie V McLaughlin; James R Seibold
Journal:  Ann Rheum Dis       Date:  2013-05-18       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.